AZN — AstraZeneca Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Market Cap
£198.21bn
Enterprise Value
£217.54bn
Revenue
$54.07bn

REG - JPMorgan Inv. Trusts - Ten Largest Investments
17/06/2022 13:15Announcement
REG - AstraZeneca PLC - Enhertu efficacy results in HER2-low breast cancer
06/06/2022 07:00Announcement
REG - AstraZeneca PLC - Total Voting Rights
01/06/2022 15:00Announcement
REG - AstraZeneca PLC - Block listing Interim Review
01/06/2022 15:00Announcement
REG - AstraZeneca PLC - Director/PDMR Shareholding
20/05/2022 16:00Announcement
REG - JPMorgan Inv. Trusts - Ten Largest Investments
13/05/2022 13:15Announcement
REG - AstraZeneca PLC - Appointment of joint corporate brokers
09/05/2022 13:00Announcement
REG - AstraZeneca PLC - Director/PDMR Shareholding
06/05/2022 16:00Announcement
REG - AstraZeneca PLC - Farxiga HFpEF Phase III trial met primary endpoint
05/05/2022 07:15Announcement
REG - AstraZeneca PLC - Enhertu approved in US for 2L HER2+ breast cancer
05/05/2022 07:15Announcement
REG - AstraZeneca PLC - Ultomiris NMOSD Ph. III trial met primary endpoint
05/05/2022 07:00Announcement
REG - AstraZeneca PLC - Imfinzi combo granted Priority Review for BTC
04/05/2022 07:00Announcement
REG - AstraZeneca PLC - Total Voting Rights
03/05/2022 15:00Announcement
REG - AstraZeneca PLC - Result of AGM
29/04/2022 17:30Announcement
REG - AstraZeneca PLC - AstraZeneca plans new R&D centre in Massachusetts
29/04/2022 07:15Announcement
REG - AstraZeneca PLC - First quarter 2022 results
29/04/2022 07:00Announcement
REG - AstraZeneca PLC - Ultomiris approved in the US for adults with gMG
28/04/2022 07:15Announcement
REG - AstraZeneca PLC - Enhertu granted BTD for HER2-low breast cancer
27/04/2022 07:16Announcement
REG - AstraZeneca PLC - Tremelimumab US Priority Review for Imfinzi combo
25/04/2022 07:00Announcement
REG - JPMorgan Inv. Trusts - Ten Largest Investments
21/04/2022 15:30Announcement